Skip to content

Anti Mit3 Antibody Positivity C5676707

Published: July 22, 2026Updated: August 20, 2026

An autoimmune marker often found in certain inflammatory muscle conditions. Helps doctors confirm diagnosis when symptoms are present.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
K76.9
ICD-11
DA00.0
Body system
hepatobiliary
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hepatobiliary)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

pruritus

(hepatobiliary)

fatigue

(hepatobiliary)

cholestasis

(hepatobiliary)

icterus

(hepatobiliary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Immunomodulatory treatment

Treatment focuses on managing the underlying autoimmune condition associated with anti-Mi3 antibodies. Immunosuppressive therapy may be indicated depending on the specific clinical syndrome. Response depends on the type and severity of the associated autoimmune disease.

medication
3

Regular serological and clinical surveillance

Periodic assessment of antibody levels and clinical status guides treatment decisions. Surveillance for progression to defined autoimmune disease is important. Early intervention for evolving conditions improves outcomes.

monitoring

Additional treatment options

Anti-inflammatory therapy

NSAIDs or colchicine may be used for symptomatic inflammatory manifestations. These agents help control inflammation while diagnostic evaluation proceeds. Selection depends on organ involvement and symptom severity.

medication

Inflammatory load reduction

Smoking cessation, moderate alcohol consumption, and maintaining healthy weight reduce systemic inflammation. Adequate sleep and stress management support immune regulation. These measures complement medical therapies.

lifestyle

Supportive care

Physical therapy addresses musculoskeletal symptoms associated with autoimmune conditions. Nutritional support ensures adequate protein and micronutrient intake for immune function. Regular follow-up with specialists as indicated.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Mit3 Antibody Positivity C5676707?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hamaguchi Y, Kuwana M, Takehara K. Myositis-specific autoantibodies: updates on clinical and pathological associations. Curr Opin Rheumatol. 2020.

review2020
2

Lundberg IE, Tjärnlund A, Bottai M, et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for idiopathic inflammatory myopathies. Ann Rheum Dis. 2017.

guideline2017
3

Trallero-Araguás E, Rodrigo-Pendás J, Selva-O'Callaghan A, et al. Usefulness of anti-p155 and anti-Jo-1 antibodies in a cohort of myositis patients with cancer. Medicine. 2012.

other2012
4

Watad A, Abu Tailakh M, Amital H, et al. Autoimmune myositis and malignancy: a systematic review and meta-analysis. Autoimmun Rev. 2021.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Anti Mit3 Antibody Positivity C5676707. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy